# Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk

> **NCT07374978** · NA · COMPLETED · sponsor: **Ain Shams University** · enrollment: 100 (actual)

## Conditions studied

- Pulmonary Embolism Subacute Massive
- Thrombolytic Therapy

## Interventions

- **DRUG:** Thrombolytic therapy for the study group in the form of streptokinase or recombinant tissue plasminogen activator
- **DRUG:** Unfractionated Heparin IV

## Key facts

- **NCT ID:** NCT07374978
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-01
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-07-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07374978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07374978, "Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT07374978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*